NCT06113016View on ClinicalTrials.gov

Prevention of Frailty With Fisetin and Exercise in Breast Cancer Survivors

PHASE2RecruitingINTERVENTIONAL
Enrollment

164

Participants

Timeline

Start Date

July 23, 2024

Primary Completion Date

June 30, 2028

Study Completion Date

December 30, 2028

Conditions
Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Early Stage Breast Carcinoma
Interventions
PROCEDURE

Biospecimen Collection

Undergo collection of blood samples

OTHER

Educational Intervention

Receive handout on physical activity

OTHER

Exercise Intervention

Receive individually tailored exercise intervention

DRUG

Fisetin

Given PO

OTHER

Physical Performance Testing

Ancillary studies

DRUG

Placebo Administration

Given PO

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (6)

90095

RECRUITING

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

90210

RECRUITING

UCLA Health Beverly Hills Primary & Specialty Care, Beverly Hills

90292

RECRUITING

UCLA Health Primary Care in Marina del Rey, Marina del Rey

91105

RECRUITING

UCLA Health Primary Care in Pasadena, Pasadena

91505

RECRUITING

UCLA Health Burbank Primary & Specialty Care, Burbank

91801

RECRUITING

UCLA Health Cancer Care in Alhambra, Alhambra

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Cancer Institute (NCI)

NIH

collaborator

Rising Tide Foundation

OTHER

lead

Jonsson Comprehensive Cancer Center

OTHER